search
Back to results

Vitamin E-Diffused Highly Cross-Linked Polyethylene Liner

Primary Purpose

Osteoarthritis

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
E-poly
ArComXL
Sponsored by
Sahlgrenska University Hospital, Sweden
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Osteoarthritis

Eligibility Criteria

20 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • primary and certain subgroups of secondary osteoarthritis
  • Patients aged 20-75 years

Exclusion Criteria:

  • inflammatory arthritis
  • cortisone or chemotherapy treatment
  • known osteoporosis or osteomalacia

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    E-XLPE

    C-XLPE

    Arm Description

    E-poly

    ArComXL

    Outcomes

    Primary Outcome Measures

    Wear of vitamin E incorporated highly cross linked polyethylene
    Evaluation of the early bedding in and wear in an uncemented arthroplasty supplied with liners made of vitamin E diffusion doped XLPE in comparsion to annealed polyethylene liner, ArComXL.

    Secondary Outcome Measures

    Cup and stem translations
    Evaluation of cup and stem translations of vitamin E incorporated highly cross linked polyethylene compared to annealed polyethylene liner ArComXL liner.

    Full Information

    First Posted
    April 30, 2014
    Last Updated
    June 9, 2016
    Sponsor
    Sahlgrenska University Hospital, Sweden
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02801019
    Brief Title
    Vitamin E-Diffused Highly Cross-Linked Polyethylene Liner
    Official Title
    Wear and Creep of Vitamin E-Diffused Highly Cross-Linked Polyethylene Liners Randomized Radiostereometric Study of 70 Hips Followed for 2 Years
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    June 2008 (undefined)
    Primary Completion Date
    November 2011 (Actual)
    Study Completion Date
    November 2011 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Sahlgrenska University Hospital, Sweden

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Vitamin E incorporated highly cross linked polyethylene (E-XLPE) was developed to increase oxidative resistance of highly cross-linked polyethylene (XLPE) without affecting mechanical properties. The investigators evaluated this type of polyethylene in a randomized clinical study, using Radiostereometric Analysis (RSA). The objective of this study was to compare the early-term wear of E-XLPE to a compression annealed polyethylene liner (C-XLPE, ArComXL®). The clinical outcome at two years was not expected to be affected by the choice of polyethylene.
    Detailed Description
    First generation of modern highly cross-linked polyethylene (XLPE) was clinically introduced in 1998 and has in most countries become standard as bearing surface in total hip arthroplasty. Studies of these materials have shown significantly reduced femoral head penetration when compared to gamma sterilized conventional polyethylene. Thermaly treating (melting or annealing) is often a part of the manufacturing process of highly cross-linked polyethylenes. The polyethylene is exposed to irradiation to achieve cross-linking and improve wear resistance. Cross-linking by irradiation increases the amount of free radicals in the material.These radicals must be eliminated or stabilized to avoid oxidative degradation over time.Thermal treatment improves oxidation resistance but potentially changes the mechanical properties of the polyethylene. By annealing i.e. heat treatment under the melt temperature the material maintains better mechanical properties, but elimination of free radicals is suboptimal, which can lead to oxidation in vivo.Heat treatment of the polyethylene above the melt temperature will more effectively reduce or eliminate the amount of residual free radicals. This will increase oxidation resistance, but will negatively influence the mechanical properties of the material. Due to these limitations new generations of cross-linked polyethylene materials have been developed. Introducing Vitamin E (α-tocopherol), a natural antioxidant into the material prevents oxidative degradation and stabilizes the free radicals found in irradiated polyethylene plastic. In laboratory tests, polyethylene liners with incorporated vitamin-E have demonstrated similar wear, greater strength and better resistance to oxidation compared with the first generation cross-linked polyethylene. Currently, there are only laboratory studies on vitamin E diffused polyethylene available. The hypothesis in this study is that the early-term E-XLPE wear is low and comparable to a heat-treated XLPE. The investigators also hypothesize that implant fixation and clinical outcome at two years will be unaffected by the choice of polyethylene. The investigators therefore evaluated the early bedding in and wear in an uncemented arthroplasty supplied with liners made of vitamin E diffusion doped XLPE (E1®, Biomet, Warsaw, IN, USA). In the control group the investigators used the same uncemented hip prosthesis with polyethylene liners manufactured to achieve high levels of crosslinking without sacrificing the mechanical strength and extinguish residual free radicals (ArComXL® , Biomet, Warzaw, IN, USA).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Osteoarthritis

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigator
    Allocation
    Randomized
    Enrollment
    70 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    E-XLPE
    Arm Type
    Experimental
    Arm Description
    E-poly
    Arm Title
    C-XLPE
    Arm Type
    Active Comparator
    Arm Description
    ArComXL
    Intervention Type
    Other
    Intervention Name(s)
    E-poly
    Intervention Description
    comparison of two different polyethylene plastic 0,04 mm at 3 months 0,06 at 2 years
    Intervention Type
    Other
    Intervention Name(s)
    ArComXL
    Intervention Description
    comparison of two different polyethylene plastic 0,03 mm at 3 months 0,10 mm at 2 years
    Primary Outcome Measure Information:
    Title
    Wear of vitamin E incorporated highly cross linked polyethylene
    Description
    Evaluation of the early bedding in and wear in an uncemented arthroplasty supplied with liners made of vitamin E diffusion doped XLPE in comparsion to annealed polyethylene liner, ArComXL.
    Time Frame
    up to 2 years
    Secondary Outcome Measure Information:
    Title
    Cup and stem translations
    Description
    Evaluation of cup and stem translations of vitamin E incorporated highly cross linked polyethylene compared to annealed polyethylene liner ArComXL liner.
    Time Frame
    up to 2 years
    Other Pre-specified Outcome Measures:
    Title
    Precision of the Radiostereometric analysis method
    Description
    The differences between the postoperative double-examinations was used to compute the precision for the method.
    Time Frame
    Postoperatively, whitin 3 to 5 days after surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    20 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: primary and certain subgroups of secondary osteoarthritis Patients aged 20-75 years Exclusion Criteria: inflammatory arthritis cortisone or chemotherapy treatment known osteoporosis or osteomalacia
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Johan Kärrholm, Professor
    Organizational Affiliation
    Sahlgrenska University Hospital, Sweden
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Vitamin E-Diffused Highly Cross-Linked Polyethylene Liner

    We'll reach out to this number within 24 hrs